Objectively Measured Daily Steps and Subsequent Long Term All-Cause Mortality: The Tasped Prospective Cohort Study
Terence Dwyer, Angela Pezic, Cong Sun, Jenny Cochrane, Alison Venn, Velandai Srikanth, Graeme Jones, Robin Shook, Xuemei Sui, Andrew Ortaglia, Steven Blair, Anne-Louise Ponsonby
PLOS ONE | PUBLIC LIBRARY SCIENCE | Published : 2015
The study received financial support from the National Health and Medical Research Council of Australia, the Commonwealth Department of Health and Aged Care, Abbott Australasia, Alphapharm, Aventis Pharmaceutical, AstraZeneca, Bristol-Myers Squibb Pharmaceuticals, Eli Lilly (Australia), GlaxoSmithKline, Janssen-Cilag (Australia), Merck Lipha, Merck Sharp and Dohme (Australia), Novartis Pharmaceutical (Australia), Novo Nordisk Pharmaceutical, Pharmacia and Upjohn, Pfizer, Roche Diagnostics, Sanofi Synthelabo (Australia), Servier Laboratories (Australia), BioRad Laboratories, Hitech Pathology, the Australian Kidney Foundation, Diabetes Australia, Tasmanian Department of Health and Human Services, the Physiotherapy Research Foundation, Perpetual Trustees, Brain Foundation, Royal Hobart Hospital Research Foundation, ANZ Charitable Trust, Tasmanian Community Fund; Arthritis Foundation of Australia and Masonic Centenary Medical Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.We thank Amanda Hawker for cohort data management and Helen Raschella and Rianna Chapman for manuscript preparation. We thank Andrew Kemp for literature review. This work was supported by the Victorian Government's Operational Infrastructure Support Program.